rhNGF 180 µg/ml eye drops solution

DRUG2 trials

Sponsors

Dompé Farmaceutici S.p.A, Ospedale San Raffaele

Conditions

Cystoid Macular EdemaRetinitis Pigmentosa

Phase 1

A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)

CompletedNCT02110225

Dompé Farmaceutici S.p.ARetinitis Pigmentosa

Start: 2014-01-31End: 2015-11-30Updated: 2024-04-18

Phase 2

Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema

CompletedNCT02609165

Ospedale San RaffaeleCystoid Macular Edema, Retinitis Pigmentosa

Start: 2015-05-31End: 2017-02-28Updated: 2017-09-06